Stocks and Investing Stocks and Investing
Thu, April 28, 2022
[ 12:00 AM ] - WOPRAI
Mehdi Hosseini Maintained (STX) at Sell with Increased Target to $67 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ned Baramov Maintained (SUN) at Hold with Increased Target to $46 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Spak Maintained (TEL) at Buy with Increased Target to $158 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
David Kelley Maintained (TEL) at Strong Buy and Held Target at $160 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Joshua Tilton Maintained (TENB) at Buy with Increased Target to $75 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Kevin Garrigan Maintained (TER) at Strong Buy with Decreased Target to $155 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ryan Daniels Downgraded (TDOC) to Hold on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Stephanie Davis Demko Downgraded (TDOC) to Hold and Decreased Target to $35 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ryan MacDonald Maintained (TDOC) at Strong Buy with Decreased Target to $48 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Yong Downgraded (TDOC) to Hold and Decreased Target to $35 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Stan Berenshteyn Downgraded (TDOC) to Hold and Held Target at $40 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Grosslight Downgraded (TDOC) to Hold and Decreased Target to $43 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Sandy Draper Downgraded (TDOC) to Hold on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Sean Dodge Maintained (TDOC) at Buy with Decreased Target to $65 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
George Hill Maintained (TDOC) at Hold with Decreased Target to $44 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Richard Close Maintained (TDOC) at Strong Buy with Decreased Target to $50 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Matt Hewitt Maintained (TDOC) at Hold with Decreased Target to $30 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Laurie Havener Downgraded (CLBK) to Hold on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ben Hendrix Maintained (CHE) at Buy with Increased Target to $592 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Gabriela Borges Initiated (CCCS) at Hold and Held Target at $11 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (CCK) at Buy with Increased Target to $143 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (SRDX) at Strong Buy with Decreased Target to $46 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ryan Levine Maintained (SRE) at Hold with Increased Target to $86 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Justin Patterson Maintained (SPOT) at Buy with Decreased Target to $210 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Wlodarczak Downgraded (SPOT) to Hold and Held Target at $110 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Barton Crockett Maintained (SPOT) at Hold with Decreased Target to $101 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Steven Cahall Maintained (SPOT) at Sell with Decreased Target to $101 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Mario Lu Maintained (SPOT) at Buy with Decreased Target to $170 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Ned Baramov Maintained (SPH) at Hold with Increased Target to $19 on, Apr 28th, 2022
[ 12:00 AM ] - WOPRAI
Robin Garner Initiated (XERS) at Strong Buy and Held Target at $6.5 on, Apr 28th, 2022

Robin Garner Initiated (XERS) at Strong Buy and Held Target at $6.5 on, Apr 28th, 2022


Published on 2024-10-27 20:41:41 - WOPRAI, Robin Garner
  Print publication without navigation


Robin Garner of Craig-Hallum, Initiated "Xeris Biopharma Holdings, Inc." (XERS) at Strong Buy and Held Target at $6.5 on, Apr 28th, 2022.

Robin has made no other calls on XERS in the last 4 months.



There are 3 other peers that have a rating on XERS. Out of the 3 peers that are also analyzing XERS, 0 agree with Robin's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Robin

  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, March 16th, 2022
  • Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $6 on, Wednesday, February 16th, 2022
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $5.4 on, Friday, December 31st, 2021
Contributing Sources